China SXT Pharmaceuticals Statistics Share Statistics China SXT Pharmaceuticals has 116.03M
shares outstanding. The number of shares has increased by 5890.12%
in one year.
Shares Outstanding 116.03M Shares Change (YoY) 5890.12% Shares Change (QoQ) 89.11% Owned by Institutions (%) 0.04% Shares Floating 115.72M Failed to Deliver (FTD) Shares 39 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 49.13K, so 0.04% of the outstanding
shares have been sold short.
Short Interest 49.13K Short % of Shares Out 0.04% Short % of Float 0.04% Short Ratio (days to cover) 1.34
Valuation Ratios The PE ratio is -0.3 and the forward
PE ratio is null.
China SXT Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.3 Forward PE n/a PS Ratio 0.58 Forward PS n/a PB Ratio 0.07 P/FCF Ratio -0.43 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for China SXT Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.54,
with a Debt / Equity ratio of 0.06.
Current Ratio 3.54 Quick Ratio 3.4 Debt / Equity 0.06 Debt / EBITDA -0.38 Debt / FCF -0.42 Interest Coverage -4.14
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $23.21K Profits Per Employee $-44.05K Employee Count 75 Asset Turnover 0.08 Inventory Turnover 1.66
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -81.01% in the
last 52 weeks. The beta is 1.25, so China SXT Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.25 52-Week Price Change -81.01% 50-Day Moving Average 1.69 200-Day Moving Average 2.76 Relative Strength Index (RSI) 46.93 Average Volume (20 Days) 579,582
Income Statement In the last 12 months, China SXT Pharmaceuticals had revenue of 1.74M
and earned -3.3M
in profits. Earnings per share was -8.18.
Revenue 1.74M Gross Profit 367.43K Operating Income -2.68M Net Income -3.3M EBITDA -2.57M EBIT -2.66M Earnings Per Share (EPS) -8.18
Full Income Statement Balance Sheet The company has 18.1M in cash and 983.88K in
debt, giving a net cash position of 17.12M.
Cash & Cash Equivalents 18.1M Total Debt 983.88K Net Cash 17.12M Retained Earnings -28.02M Total Assets 21.66M Working Capital 15.28M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -2.35M
and capital expenditures -2.02K, giving a free cash flow of -2.35M.
Operating Cash Flow -2.35M Capital Expenditures -2.02K Free Cash Flow -2.35M FCF Per Share -5.81
Full Cash Flow Statement Margins Gross margin is 21.11%, with operating and profit margins of -153.97% and -189.77%.
Gross Margin 21.11% Operating Margin -153.97% Pretax Margin -189.77% Profit Margin -189.77% EBITDA Margin -147.8% EBIT Margin -153.97% FCF Margin -134.84%
Dividends & Yields SXTC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for SXTC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 5, 2023. It was a
backward
split with a ratio of 1:25.
Last Split Date Oct 5, 2023 Split Type backward Split Ratio 1:25
Scores Altman Z-Score 17.91 Piotroski F-Score 5
